← Evidence map

ArticleTherapeutic innovation & regulatory science2026

Why MASLD Trials Underselect the MENA Region Sites and What Sponsors and Regulators Must Change.

Mohamed El-Kassas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42034877